Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Verisante Technology Inc

+ Add to Watchlist

V3T:GR

0.056 EUR 0.007 14.29%

As of 15:44:48 ET on 05/22/2015.

Snapshot for Verisante Technology Inc (V3T)

Open: 0.053 Day's Range: 0.049 - 0.056 Volume: 0
Previous Close: 0.049 52wk Range: 0.048 - 0.142 1-Yr Rtn: -46.15%

Stock Chart for V3T

No chart data available.
  • V3T:GR 0.053
  • 1D
  • 1M
  • 1Y
0.049
Interactive V3T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V3T

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 5.07
Shares Outstanding (M) 90.59
30 Day Average Volume 350
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V3T

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for V3T

Verisante Technology Inc. is a medical device company committed to developing systems for the early detection of cancer. The Company's initial focus is skin cancer, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

Thomas BraunChairman/President/CEO/FounderAnna TrinhChief Financial Officer
More Company Profile & Key Executives for V3T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil